| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 21,510 | 21,223 | 20,758 | 18,322 | | Cost of Revenue | 4,905 | 5,564 | 5,863 | 4,777 | | | Gross Profit | 16,605 | 15,659 | 14,895 | 13,545 | | | Operating Expenses | | Research Development | 2,749 | 2,214 | 1,990 | 2,403 | | Selling General and Administrative | 11,747 | 11,482 | 11,456 | 12,834 | | Non Recurring |
-
|
-
| 462 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,109 | 1,963 | 987 | (1,692) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,839 | 785 | (403) | (957) | | Earnings Before Interest And Taxes | 3,948 | 2,748 | 584 | (2,649) | | Interest Expense | 29 | 36 | 38 | 10 | | Income Before Tax | 3,919 | 2,712 | 546 | (2,659) | | Income Tax Expense | 313 | 448 | (30) | (367) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,606 | 2,264 | 576 | (2,292) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,606 | 2,264 | 576 | (2,292) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,606 | $2,264 | $576 | ($2,292) |
|
0.51% Nasdaq 
0.03 (0.20%) 
Income Statement
